Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil in Preclinical Systolic Dysfunction and Renal Dysfunction
NCT01970176Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2014
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tadalafil in cardiomyopathy, renal impairment (RI), sponsored by Mayo Clinic. Started Jan 2014; status: completed.
02
Drugs
tadalafil
03
Conditions
cardiomyopathyrenal impairment (RI)
Beyond the preview
Go deeper on NCT01970176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01970176.